Abstract
A variety of viruses show specific binding to glycans on the cellular surface, such as sialoglycoconjugates, glycosaminoglycans, and histo-blood group antigens. The viral surface proteins recognize terminal sugar chain moieties of glycan and select glycans for binding to specific tissues and hosts. For example, orthomyxoviruses (influenza viruses) and paramyxoviruses recognize terminal moieties of sialic acid linked to galactose for infecting target cells. In most cases, glycans are thought to be involved in cellular surface attachment and cell entry of viruses, as viral receptors and/or coreceptors. Expression of sugar chain moieties is generally dependent on specific tissues, cells, and hosts. Therefore, the specific interactions of viruses with glycans significantly affect tissue tropism and pathogenicity by selection of the viral replication site. For example, human influenza A virus preferentially binds to sialic acid α2,6 linkage to galactose, which is expressed in the human upper respiratory tract. On the other hand, avian influenza A virus preferentially binds to sialic acid α2,3 linkage to galactose, which is expressed in chicken eggs and trachea. The difference in recognition is believed to determine host specificity of influenza A virus. Platforms of the sugar chain are N-linked glycan, O-linked glycans (containing proteoglycans), and sphingolipid. Difference in these platforms also affects functions of viral receptors. This chapter presents a review about glycans bound and recognized by representative viruses including coronavirus, flavivirus, herpesvirus, norovirus, orthomyxovirus, paramyxovirus, parvovirus, polyomavirus, retrovirus, and reovirus.
The original version of this chapter was revised. An erratum to this chapter can be found at http://dx.doi.org/10.1007/978-4-431-55381-6_18
An erratum to this chapter can be found at http://dx.doi.org/10.1007/978-4-431-55381-6_18
You have full access to this open access chapter, Download chapter PDF
Similar content being viewed by others
Keywords
- Binding
- Heparan sulfate
- Histo-blood group antigens
- Infection
- Glycan
- Receptor
- Sialic acid
- Sugar chain
- Sulfatide
- Virus
5.1 Introduction
All viruses replicate in host cells only and show host (cell) ranges and specificities. Glycans on the cellular surface are highly diverse and species specific. Viral host (cell) ranges and specificities are often dependent on specificity and diversity of glycans on the surface membranes of host cells. In fact, various viruses bind to glycans on the surface membranes of host cells as specific receptors. Typical receptors are sialic acid-containing glycans and sulfated glycans, for example, gangliosides and heparan sulfate, respectively. In many cases, the minus charge of sialic acid and sulfate is likely to play an important role in viral binding with glycans. The typical life cycle of an enveloped virus consists of receptor binding, entry, uncoating of the viral capsid, synthesis of viral components (genomes and proteins), glycosylation of viral proteins, intracellular traffic of viral components, packaging of viral particles, and budding and release of progeny viruses on the cellular surface. Functions of glycans in these steps except for receptor binding mostly remain unknown. This chapter presents a review, mainly in terms of a viral receptor, about glycans recognized by viruses including coronavirus, flavivirus, herpesvirus, norovirus, orthomyxovirus, paramyxovirus, parvovirus, polyomavirus, retrovirus, and reovirus.
5.2 Viruses that Bind to Glycans
5.2.1 Coronavirus
Coronaviruses are positive-stranded RNA viruses and enveloped viruses that are classified within the family Coronaviridae. They are a diverse group of viruses that infect various mammalian and avian species. The viruses often affect the respiratory or intestinal tract. It has been shown that many coronaviruses agglutinate erythrocytes (Bingham et al. 1975; Pokorný et al. 1975). Coronaviruses recognize a type of sialic acid as a receptor on cell surface components. Bovine coronavirus (BCV) and human coronavirus OC43 strain (HCoV-OC43) have binding activity to glycoconjugates containing N-acetyl-9-O-acetylneuraminic acid (Neu5,9Ac2), through hemagglutinin-esterase (HE) protein and/or spike (S) protein on the viral surface membrane (Schultze et al. 1991a, b; Künkel and Herrler 1993). The HE protein only agglutinates cells that contain a high content of Neu5,9Ac2 such as mouse and rat erythrocytes (Schultze et al. 1991b). The S protein is able to agglutinate chicken erythrocytes, but the HE protein cannot (Schultze et al. 1991a). Bovine coronavirus is more efficient in recognizing Neu5,9Ac2 α2,3-linked to galactose (Neu5,9Ac2α2,3Gal), whereas HCoV-OC43 is superior with respect to Neu5,9Ac2 α2,6-linked to galactose (Neu5,9Ac2α2,6Gal) (Krempl et al. 1995). BCV and HCoV-OC43 use Neu5,9Ac2 as a receptor to initiate infection of cultured cells (Schultze and Herrler 1992; Künkel and Herrler 1993). These viruses also have esterase activity in the HE protein to cleave the 9-O-acetyl group of Neu5,9Ac2, as does influenza C virus (ICV). The esterase activity is believed to help release of progeny viruses from cellular surfaces of host cells. In contrast to most of the coronaviruses, mouse hepatitis virus (MHV) recognizes N-acetyl-4-O-acetylneuraminic acid (Neu4,5Ac2) rather than Neu5,9Ac2 (Regl et al. 1999; Langereis et al. 2012). Receptor recognition of MHV may reflect change in host tropism from other species to mice.
Porcine transmissible gastroenteritis virus (TGEV) and avian infectious bronchitis virus (AIBV) bind to N-acetylneuraminic acid (Neu5Ac) α2,3-linked to galactose (Neu5Acα2,3Gal) (Schultze et al. 1992, 1993) via viral S protein. TGEV infects the porcine small intestine, brush border membranes of which express mucin-like and Neu5Ac-rich glycoprotein. Although TGEV uses aminopeptidase N as the main cellular receptor, TGEV S protein may support viral attachment to the brush border membranes (Schwegmann-Wessels and Herrler 2008). TGEV also recognizes N-glycolylneuraminic acid (Neu5Gc) (Schultze et al. 1996), which is expressed in pigs (Suzuki et al. 1997). S protein of AIBV shows much higher binding activity to Neu5Acα2,3Gal than does that of TGEV. AIBV uses only Neu5Ac as the main cellular receptor (Winter et al. 2006; Shahwan et al. 2013). AIBV Beaudette strain shows binding activity to heparan sulfate (HS). This virus is an embryo-adapted virus that has the extended tropism in cell culture. HS may in part contribute to extended tropism of AIBV Beaudette strain (Madu et al. 2007) (Table 5.1).
5.2.2 Flavivirus
Flaviviruses are positive-stranded RNA viruses and enveloped viruses that are classified within the family Flaviviridae. Dengue virus (DEN) is the most important mosquito-mediated human pathogen. Clinical manifestations of the virus range from a simple self-limited febrile illness known as dengue fever to a hemorrhagic fever and potentially fatal hemorrhagic shock syndrome. All serotypes (1–4) of DEN recognize nLc4Cer (Galβ1,4GlcNAcβ1,3Galβ1,4Glc1,1’Cer) from mammalian cells (Aoki et al. 2006). DEN type 2 also recognizes Ar3Cer (GlcNAcβ1,3Manβ1,4Glcβ1,1’Cer) from mosquito cells (Wichit et al. 2011). It is thought that neutral glycosphingolipids share the important determinant for DEN binding and that the β-GlcNAc residue may play a key role in DEN binding. Chemically synthesized derivatives carrying multiple carbohydrate residues of nLc4 inhibit binding of DEN type 2, indicating that a binding inhibitor based on nLc4 could be as a potential DEN drug (Aoki et al. 2006). DEN also binds to some glycosaminoglycans (GAGs) such as HS (Chen et al. 1997; Watterson et al. 2012), heparin (Marks et al. 2001), fucoidan (Hidari et al. 2008), and chondroitin sulfate E (Kato et al. 2010) through the virus envelope E glycoprotein, but does not bind to chondroitin sulfates A, B, C, and D or hyaluronic acid (Kato et al. 2010). DEN infection is inhibited by some GAGs such as heparin (Marks et al. 2001), fucoidan (Hidari et al. 2008), and chondroitin sulfate E (Kato et al. 2010). Most GAGs include GlcA and sulfated GlcA. 3-O-Sulfated GlcA inhibits DEV infection, but 2-O-sulfated and 3,6-di-O-sulfated ones do not (Hidari et al. 2012). It is thought that 3-O-GlcA is in part a key structure in DEN binding to GAGs. DEN causes leakage of the vascular endothelium, resulting in dengue hemorrhagic fever. Human endothelial cells are highly susceptible to infection by DEN. The susceptibility may be attributed to DEN attachment directed to HS-containing proteoglycan receptors on endothelial cells (Dalrymple et al. 2011). Two encephalitis flaviviruses, Japanese encephalitis virus (JEV) and West Nile virus (WNV), have a binding activity to heparin (Lee et al. 2004). JEV also binds to and is inhibited by HS (Su et al. 2001). The binding affinity of WNV and JEV for GAG has been suggested to be a determinant for the neuroinvasiveness of encephalitic flaviviruses (Lee et al. 2004).
E1 and E2 envelope glycoproteins of hepatitis C virus (HCV) recognize HS through an important structure such as 6-O-sulfation and N-sulfation, not through simple ionic interactions (Barth et al. 2003; Kobayashi et al. 2012). Since HCV strongly binds to HS from liver tissues, HS appears to be one of the molecules that confer the liver-specific tissue tropism of HCV infection (Kobayashi et al. 2012). Binding of HCV to the cell surface is not markedly inhibited by heparin, different from other flaviviruses such as DEN and JEV. Cellular HS may act as an alternative receptor for HCV, not a primary receptor (Heo 2008). However, chondroitin sulfate E from squid cartilage strongly interacts with both E1 and E2 proteins and inhibits the entry of pseudotype HCV into cells, suggesting that chondroitin sulfate E is a potential candidate of an anti-HCV drug (Kobayashi et al. 2012). Apolipoprotein E (ApoE), which has a heparin-binding activity, mediates HCV attachment to the cell surface through specific interactions with cellular HS (Jiang et al. 2012). Syndecan-1, which is a core protein to form HS proteoglycans, serves as the major receptor protein for HCV attachment to cells (Shi et al. 2013).
Sulfated GAGs (especially HS) may serve as receptor proteoglycans for the attachment of flaviviruses to target cells. Elucidation of the mechanism by which flaviviruses bind to sulfated GAGs would contribute to the discovery and development of anti-flavivirus drugs (Table 5.2).
5.2.3 Herpesvirus
Herpesviruses are double-stranded linear DNA viruses and enveloped viruses that are classified within the family Herpesviridae. The most common manifestations of herpes simplex virus (HSV) infection are mucocutaneous lesions. The initial contact of HSV serotypes 1 and 2 (HSV-1 and HSV-2) with the cellular surface is believed to be binding of the virus to HS through the viral envelope glycoproteins gB and gC (Herold et al. 1991; Trybala et al. 2000). However, interactions of gB and gC with HS are not sufficient for HSV entry into cells. After adsorption of HSV with HS on the cellular surface, cell entry requires engagement of the viral envelope glycoprotein gD with one of three classified coreceptors, herpesvirus entry mediator, tumor necrosis factor (TNF) receptor family, and immunoglobulin superfamily (Spear et al. 2000). Additionally, 3-O-sulfation of glucosamine residues in HS generated by multiple D-glucosaminyl 3-O-sulfotransferase isoforms is a key determinant of the gD binding site. HSV-1 cell entry requires interactions of gD with 3-O-sulfated HS or other coreceptors described above (Shukla et al. 1999). 3-O-Sulfated HS appears to play an important role in HSV-1 entry into many different cell lines (O’Donnell et al. 2010). The glycoprotein gB has a sequence of a putative fusion activity, suggesting that interactions of gB with cellular surface molecules allow the fusion process for cell entry. However, HS-deficient cells are susceptible to HSV-1 infection (Banfield et al. 1995). HSV-1 bearing gB lacking an HS binding site also maintains cell infectivity (Laquerre et al. 1998). Soluble gB, which was generated by a baculovirus protein expression system, also binds to HS-deficient cells and inhibits HIV-1 infection (Bender et al. 2005). Interaction of gB with other molecules except HS may play an important role in HSV-1 infection. 3-O-Sulfated HS and HS-binding peptide have been investigated as anti-HSV agents (Copeland et al. 2008; Ali et al. 2012) (Table 5.3).
5.2.4 Norovirus
Human noroviruses (NoVs) are single-stranded positive-sense RNA viruses and small, round, non-enveloped viruses with a diameter of 38 nm that are classified within the family Caliciviridae. These viruses are the major causative pathogens of acute viral gastroenteritis characterized by severe diarrhea. NoV virus-like particles (VLPs) bind to histo-blood group antigens demonstrating A, B, and O phenotypes, through the P domain of viral capsid protein, VP1 (Harrington et al. 2002; Marionneau et al. 2002; Chen et al. 2011). For example, the VLPs derived from Norwalk/68 strain bind to H1 antigen (Fucα1,2Galβ1,3GlcNAc; O phenotype), H2 antigen (Fucα1,2Galβ1,4GlcNAc; O phenotype), Leb antigen [Fucα1,2Galβ1,3(Fucα1,4)GlcNAc], A1 antigen [GalNAcα1,3(Fucα1,2)Galβ1,3GlcNAc; A phenotype], and A2 antigen [GalNAcα1,3(Fucα1,2)Galβ1,4GlcNAc; A phenotype] but not to B1 antigen [Galα1,3(Fucα1,2)Galβ1,3GlcNAc, B phenotype] or B2 antigen [Galα1,3(Fucα1,2)Galβ1,4GlcNAc, B phenotype] (Harrington et al. 2002; Huang et al. 2003, 2005; Hutson et al. 2003; Lindesmith et al. 2003). Humans with O phenotype, but not those with B phenotype, are susceptible to NoV Norwalk/68 strain infection (Hutson et al. 2002; Lindesmith et al. 2003). These studies suggested that histo-blood group antigens are receptors of NoV. However, other NoV VLPs display different ABH and Lewis carbohydrate-binding profiles (Harrington et al. 2002; Huang et al. 2005; Shirato et al. 2008; Shirato-Horikoshi et al. 2007). Indeed, Rockx’s epidemiological research indicated that some NoVs can infect individuals with different ABH phenotypes (Rockx et al. 2005). For example, VLPs derived from BUDS strain bind to A and B antigens but not to H antigens. The binding activities of NoVs to histo-blood group antigens vary greatly in a strain-dependent manner. NoVs include at least 36 genotypes in VP1 nucleotide sequence. Various genotype NoVs appear to infect humans with any blood types through binding combinations of some histo-blood group antigens (Table 5.4).
5.2.5 Orthomyxovirus
Representative orthomyxoviruses are influenza A virus (IAV), influenza B virus (IBV), and ICV, which are classified within the family Orthomyxoviridae. Influenza viruses are enveloped viruses with a diameter of 100 nm and are respiratory pathogens with strong infection spread. IAVs and IBVs are eight-segmented single-stranded negative-sense RNA viruses, and ICVs are seven-segmented single-stranded negative-sense RNA viruses. Viral hosts are wide species including humans, pigs, birds, and horses for IAVs and mainly humans for IBVs and ICVs. Host receptors on the cellular surface membrane are sialic acid residues existing at the terminal position of glycoconjugates, Neu5Ac for IAVs and IBVs and Neu5,9Ac2 for ICVs (Rogers et al. 1986; Suzuki et al. 1992). IAVs and IBVs have sialidase activity (an enzyme cleaving Neu5Ac from glycoconjugates), and ICVs also have esterase activity (an enzyme cleaving 9-O-acetyl group from Neu5,9Ac2) to prevent trapping of progeny viruses to sialic acid residues on the cellular surface and on viral glycoproteins. These receptors containing sialic acids are thought to be gangliosides and/or N-glycans (Suzuki 1994; Chu and Whittaker 2004). In general, human IAVs show preferential binding to Neu5Acα2,6Gal linkage, whereas avian IAVs show preferential binding to Neu5Acα2,3Gal linkage. Swine IAVs bind to both Neu5Acα2,3Gal and Neu5Acα2,6Gal linkages, equally or with predominance toward Neu5Acα2,6Gal linkage (Ito et al. 1997a; Suzuki et al. 1997). IBVs show preferential binding to Neu5Acα2,6Gal linkage (Suzuki et al. 1992). IAVs and IBVs strongly recognize Neu5Acα2,6(or 3)Galβ1,3GlcNAc and Neu5Acα2,6(or 3)Galβ1,4GlcNAc through interactions of the viral surface glycoprotein, hemagglutinin (HA) (Suzuki et al. 1992, 2000; Suzuki 1994). The human trachea predominantly expresses Neu5Acα2,6Gal linkage (Baum and Paulson 1990). The pig trachea expresses both Neu5Acα2,3Gal and Neu5Acα2,6Gal linkages (Suzuki et al. 1997, 2000). Chicken eggs and trachea express Neu5Acα2,3Gal linkage (Ito et al. 1997b; Abd El Rahman et al. 2009). Glycoconjugates recognized by respective IAVs coincide with respective virus replication sites expressing their glycoconjugates, strongly suggesting that their glycoconjugates are receptors of IAVs. Some H5N1 highly pathogenic avian IAVs (HPAIs) and H7N9 avian IAVs, isolated from humans, show increased binding activity to Neu5Acα2,6Gal linkage (Yamada et al. 2006; Watanabe et al. 2013; Zhang et al. 2013). Acquisition of Neu5Acα2,6Gal linkage binding activity of H5N1 HPAIs is one of the factors that lead to airborne transmission among ferrets (human infection and transmission model) (Imai et al. 2012; Herfst et al. 2012). Increased binding activity of avian IAVs and animal IAVs other than human IAVs to Neu5Acα2,6Gal linkage could cause a pandemic of a new subtype of IAV among humans. As an alternate pandemic mechanism, a new subtype of IAV could arise by genetic reassortment among segmented viral RNAs from simultaneous infections of human and avian IAVs in pigs, which express both Neu5Acα2,3Gal and Neu5Acα2,6Gal linkages in the trachea. In this way, Neu5Ac binding properties of IAVs may be involved in the pandemic occurrence of a new subtype of IAV.
Since 2008, it has been reported that some IAVs, 2009 pandemic H1N1 IAVs and avian IAVs including H5, H6, H7, and H9 subtypes, show preferential binding to 6-sulfo sialyl Lewis X. These IAVs appear to recognize terminal tri- or tetra-oligosaccharides [Neu5Acα2,3Galβ1,4(6-O-SO3H)GlcNAc and Neu5Acα2,3Galβ1,4(Fucα1,3)(6-O-SO3H)GlcNAc] of 6-sulfo sialyl Lewis X (Gambaryan et al. 2008, 2012; Childs et al. 2009).
Major sialic acids are classified into two types: Neu5Ac and Neu5Gc. Almost all equine IAVs show strong preferential binding to Neu5Gc α2,3-linked to galactose (Neu5Gcα2,3Gal) (Ito et al. 1997a; Suzuki et al. 2000). Almost all avian IAVs also show binding activity to one, although Neu5Gc binding activity is weaker than their Neu5Ac binding activity (Ito et al. 1997a, 2000). Some human and swine IAVs show binding activity to Neu5Gc (preferentially to Neu5Gcα2,6Gal linkage) (Suzuki et al. 1997; Masuda et al. 1999; Takahashi et al. 2009). Neu5Gc and Neu5Gcα2,3Gal linkage is expressed in the horse trachea, duck intestine, and pig trachea, which are natural replication sites of IAVs (Suzuki et al. 1997, 2000; Ito et al. 2000). The function of Neu5Gc is predicted to be an IAV receptor, like Neu5Ac. There is a possibility that human and avian IAVs facilitate transmission to pigs through interactions with Neu5Gc. As described above, pigs are potential intermediate hosts that produce a new subtype of IAV between human IAV and avian IAV. Neu5Gc binding properties of these IAVs may also be involved in a pandemic occurrence.
Sulfatide is a 3-O-sulfated galactosylceramide (GalCer). IAV specifically binds to sulfatide, even though it does not contain any sialic acids (Suzuki et al. 1996). Sulfatide is not an IAV receptor for initial infection, different from sialic acids. Caspase-3-dependent apoptosis enhances IAV replication through enhancement of nuclear export of viral ribonucleoprotein complexes (vRNP) (Wurzer et al. 2003). Sulfatide has interacted with newly synthesized HA transferred to the surface membranes of infected cells. The interaction of HA with sulfatide facilitates formation and replication of progeny virus particles through enhancement of nuclear export of vRNP by inducing caspase-3-independent apoptosis (Takahashi et al. 2008, 2010, 2013b). The binding mechanism of the HA ectodomain with sulfatide is thought to be different from that with Neu5Ac (Takahashi et al. 2013a). An inhibitor of HA binding with sulfatide would become a novel drug that inhibits formation of IAV particles and IAV replication. Sulfatide is involved in various biological properties such as the immune system, nervous system, kidney functions, insulin control, hemostasis/thrombosis, cancer, and other microbes (Takahashi and Suzuki 2012). Further study on sulfatide binding of IAVs would contribute to elucidation of these biological mechanisms and diseases associated with sulfatide (Table 5.5).
5.2.6 Paramyxovirus
Paramyxoviruses are single-stranded negative-sense RNA viruses and enveloped viruses with a diameter of 150–250 nm that are classified within the family Paramyxoviridae. Some paramyxoviruses have the envelope glycoprotein, hemagglutinin-neuraminidase (HN), displaying both sialic acid binding activity and sialidase activity. Such viruses that infect humans are human parainfluenza virus (hPIV) and mumps virus (MuV), which are members of the genus Respirovirus and Rubulavirus, respectively. hPIVs [mainly type 1 (hPIV1) and type 3 (hPIV3)] account for 20 % of causative pathogens isolated from children with pneumonia (Sinaniotis 2004). hPIV1 causes most cases of laryngotracheobronchitis (croup) in children, and hPIV type 3 (hPIV3) often causes pneumonia and bronchiolitis in infants younger than 6 months of age. hPIV1 shows preferential binding to Neu5Acα2,3Galβ1,3GlcNAc (Suzuki et al. 2001; Tappert et al. 2011), whereas hPIV3 shows binding activity to both Neu5Acα2,3Galβ1,3GlcNAc and Neu5Acα2,6Galβ1,3GlcNAc, in addition to Neu5Gcα2,3Galβ1,3GlcNAc. Higher pathogenicity of hPIV3 may be involved in the broader range of receptor recognition than that of hPIV1. Interestingly, both hPIVs strongly bind to oligosaccharides containing branched N-acetyllactosaminoglycans (Suzuki et al. 2001). Blood group I-type polylactosamine antigens may be major receptors of hPIVs. Also, HS binding of hPIV3 suggests that HS may play an important role in cell entry of hPIV3 (Bose and Banerjee 2002). On the other hand, sulfatide, which binds to hPIV3, inhibits hPIV3 infection and multinucleated syncytial giant cell formation of infected cells through suppression of viral fusion activity (Takahashi et al. 2012). MuV is a causative pathogen of childhood disease manifested by swelling of parotid glands and salivary glands, sometimes accompanied by complications such as aseptic meningitis, meningoencephalitis, and orchitis. MuV also has an HN spike protein, which was shown to be sensitive to the sialidase inhibitor 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (Waxham and Wolinsky 1986). However, binding of MuV with sialoglycoconjugates remains unknown.
Sendai virus (SeV) is a highly transmissible animal respiratory virus in mice, hamsters, guinea pigs, and rats. SeV is a member of the genus Respirovirus possessing HN. Gangliosides and glycophorin were investigated as host cell receptors for SeV (Markwell et al. 1981; Hansson et al. 1984; Suzuki et al. 1985; Wybenga et al. 1996). SeV recognizes ganglio-series gangliosides (GD1a, GT1b, and GQ1b) containing the sequence NeuAcα2,3Galβ1,3GalNAc as viral receptors (Markwell et al. 1981). SeV shows preferential binding to neolacto-series gangliosides containing Neu5Acα2,3Galβ1,4GlcNAc, especially branched blood group I-type and/or linear i-type gangliosides (Suzuki et al. 1985). SeV can also bind to bovine erythrocyte glycoprotein GP-2 containing blood group I-type branched polylactosamine oligosaccharides with Neu5Gcα2,3Gal (Suzuki et al. 1983, 1984). Neu5Gc is expressed in animals other than humans (genetically lacking an active enzyme for synthesis of Neu5Gc in humans). SeV can utilize both species of sialic acid Neu5Ac and Neu5Gc to infect animals.
Newcastle disease virus (NDV) is a transmissible pathogen of bird disease and sometimes of mild conjunctivitis and influenza-like symptoms for human infection. NDV is a member of the genus Avulavirus possessing HN. NDV shows preferential binding to gangliosides such as sialylparagloboside (IV3Neu5Acα-nLc4Cer or IV3Neu5Gcα-nLc4Cer) containing Neu5Acα2,3Galβ1,4GlcNAc or Neu5Gcα2,3Galβ1,4GlcNAc and GM3 containing Neu5Acα2,3Gal or Neu5Gcα2,3Gal. NDV also binds to blood group I-type gangliosides, GD3, GM1a, and GD1b, although their binding is weaker than that of sialylparagloboside and GM3 (Suzuki et al. 1985). Gangliosides (GM1, GM2, GM3, GD1a, GD1b, and GT1b) may act as primary receptors, and N-linked glycoproteins may function as secondary receptors for NDV entry into cells (Ferreira et al. 2004). On the other hand, pretreatment of chicken East Lansing Line ELL-0 cells with both α2,3- and α2,6-specific sialidases and α2,3(N)- and α2,6(N)-sialyltransferase incubation showed that both α2,3- and α2,6-linked sialic acids containing glycoconjugates may be used for NDV infection (Sánchez-Felipe et al. 2012). Receptor binding properties of NDVs may depend on the viral strain.
Human respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract diseases in infants and young children. RSV is a member of the genus Pneumovirus possessing viral surface glycoproteins, attachment G and fusion F proteins, but not including sialidase unlike all paramyxoviruses described above. For virus infection, RSV requires interactions of the G protein and/or the F protein with heparin, HS, and chondroitin sulfate B on the cell surface (Bourgeois et al. 1998; Feldman et al. 1999; Hallak et al. 2000). The G protein and the F protein independently recognize heparin and HS (Feldman et al. 2000). These GAGs and their destroying enzymes also have inhibitory activity against RSV infection (Hallak et al. 2000) (Table 5.6).
5.2.7 Parvovirus
Parvoviruses are non-enveloped viruses that belong to the family Parvoviridae. Adeno-associated virus (AAV) is a nonpathogenic human parvovirus with diameters of 20–30 nm. Recombinant AAV has been used for gene transfer to various cells and several organs. AAV type 1 (AAV1), type 4 (AAV4), type 5 (AAV5), and type 6 (AAV6) recognize sialic acids and use them as receptors of infection, but AAV type 2 (AAV2) and type 9 (AAV9) do not. AAV4 specifically recognizes Neu5Acα2,3Gal of O-linked glycans, whereas AAV1 and AAV6 specifically recognize both Neu5Acα2,3Gal and Neu5Acα2,6Gal of N-linked glycans. Therefore, AAV4 infection is inhibited by mucin that possesses rich O-glycans, but AAV1 and AAV6 infections are not. AAV5 binds to Neu5Acα2,3Gal of N-glycans. Binding of AAV5 to Neu5Acα2,6Gal of N-glycans remains unknown. AAV1 efficiently binds to N-linked sialylated glycans possessing lactosamine (Galβ1,4GlcNAc) (Walters et al. 2001; Kaludov et al. 2001; Wu et al. 2006). AAV2 infection is strongly or moderately inhibited by heparin or chondroitin sulfate B, respectively. HS mediates AAV2 attachment to the cellular surface and infection (Summerford and Samulski 1998). AAV9 uses the terminal Gal residue of N-linked glycans as a receptor (Shen et al. 2011).
Animal parvoviruses sometimes cause fetal diseases for hosts such as dogs and cats. Canine, feline, bovine, and mouse parvoviruses also bind to sialic acids. Bovine parvovirus (BPV) binds to Neu5Acα2,3Gal of both N- and O-linked glycans for attachment to the cellular surface (Johnson et al. 2004). BPV can strongly bind to glycophorin A through the Neu5Acα2,3Gal moiety of O-linked glycans (Blackburn et al. 2005). Parvovirus minute virus of mice (MVM) shows specific binding to terminal moieties, Neu5Acα2,3Galβ1,4GlcNAc such as sialyl Lewis X and Neu5Acα2,8Neu5Ac linkages such as gangliosides GD2, GD3, and GT3 (Nam et al. 2006). Canine parvovirus (CPV) has hemagglutination activity, indicating virus binding to sialic acid (Tresnan et al. 1995). CPV and feline parvovirus (FPV) recognize Neu5Gc but not Neu5Ac. However, Neu5Gc on the cellular surface is unlikely to be a receptor for CPV and FPV infections because overexpression of Neu5Gc has no effect on virus infectivities of some cell lines (Löfling et al. 2013) (Table 5.7).
5.2.8 Polyomavirus
JC virus (JCV) and BK virus (BKV) are non-enveloped viruses with diameters of 40–45 nm that are classified within the family Polyomaviridae, closely related to simian virus 40 (SV40) and murine polyomavirus (MPV). Initial JCV infection is thought to occur in childhood and not to cause symptomatic illness but to be a risk factor for progressive multifocal leukoencephalopathy. JCV shows stronger binding to Neu5Acα2,6Gal linkage (of N-linked glycans), in addition to binding to Neu5Acα2,3Gal linkage such as gangliosides GM3, GD2, GD3, GD1b, GT1b, and GQ1b, through the major viral capsid protein VP1 (Gee et al. 2004). A linear sialylated pentasaccharide with the sequence LSTc (Neu5Acα2,6Galβ1,4GlcNAcβ1,3Galβ1,4Glc) binds with JCV and inhibits JCV infection of target cells, strongly suggesting that LSTc is a functional receptor of JCV infection (Neu et al. 2010). JCV binds to an asialoglycolipid, lactosylceramide, but not to GalCer. Therefore, JCV can also bind to GM3 and GD3 after sialidase treatment (i.e., lactosylceramide). JCV weakly binds to GD1a but does not bind to GM1a or GM2 (Liu et al. 1998; Komagome et al. 2002). These studies suggest that both Neu5Acα2,3Gal and Neu5Acα2,6Gal of N-linked glycans are also used for cellular surface binding and infection of JCV (Dugan et al. 2008).
BKV infection rarely causes symptom illness in humans but can lead to polyomavirus-associated nephropathy in renal transplant recipients undergoing immunosuppressive therapy. BKV binds to a cellular receptor, Neu5Acα2,3Gal of N-linked glycans, via VP1 protein (Dugan et al. 2005, 2007). For nonhuman polyomaviruses, VP1s specifically bind to GD1a and GT1b for MPV and to GM1 for SV40, suggesting that Neu5Acα2,3Gal is a key determinant in the interactions. Gangliosides appear to transport polyoma and SV40 from the cellular surface to the endoplasmic reticulum, and then the viruses enter the nucleus to initiate infection (Tsai et al. 2003) (Table 5.8).
5.2.9 Retrovirus
Retroviruses are single-stranded positive-sense RNA and round enveloped viruses with a diameter of 100 nm that are classified within the family Retroviridae. Human immunodeficiency virus (HIV), which is a member of the genus Lentivirus, is a pathogen causing long-term and chronic disease that gradually progresses to acquired immunodeficiency syndrome. The viral surface glycoprotein gp120 of HIV binds to some glycolipids containing GalCer (Delézay et al. 1997; Hammache et al. 1998; Harouse et al. 1991), Gb3Cer (Galα1,4Galβ1,4Glc1,1’Cer) (Mahfoud et al. 2002; Lund et al. 2006), GM3 (Hammache et al. 1998), and sulfatide (Delézay et al. 1996; van den Berg et al. 1992), in addition to heparin (and HS) (Crublet et al. 2008). CD4 is a main primary receptor of HIV for viral attachment to the cellular surface. After interaction of the gp120 with CD4, these glycolipids and HS are thought to interact with gp120 and to act as coreceptors for the fusion process between the cellular membrane and viral membrane of HIV for entry into cells. However, sulfatide may not be a coreceptor for HIV because the fusion process is initiated by mediating binding to GalCer but not to sulfatide (Delézay et al. 1997; Harouse et al. 1991) (Table 5.9).
5.2.10 Reovirus
Reoviruses (ReV) are double-stranded RNA viruses and non-enveloped regular icosahedra non-enveloped viruses with a diameter of 60–80 nm that are classified within the family Reoviridae. ReVs can infect the gastrointestinal and respiratory tracts of various mammals. For humans, most children are infected by the age of 5 years. The viral attachment σ1 protein of ReVs recognizes sialic acids of glycoconjugates on the cellular surface. ReV type 1 (ReV1) binds to Neu5Acα2,3Gal and binds strongly to ganglioside GM2, which contains sialic acid linked to the inner galactose residue. The interaction of ReV1 with GM2 is involved in viral infection (Helander et al. 2003; Reiss et al. 2012). ReV type 3 (ReV3) binds to Neu5Acα2,3Gal, Neu5Acα2,6Gal, and Neu5Acα2,8Neu5Ac linkages, in addition to Neu4,5Ac2 (Gentsch and Pacitti 1987; Reiter et al. 2011). Interactions of ReV with sialic acids are believed to act for cellular surface attachment of ReV by rapid but low-affinity adhesion, followed by transition to a higher affinity interaction with an unidentified receptor for cell entry. Therefore, sialic acid is considered to be a coreceptor rather than a main receptor for ReV infection (Barton et al. 2001). ReV1 spreads to the central nervous system via a hematogenous route and infects ependymal cells in the brain, leading to nonlethal hydrocephalus. In contrast, ReV3 spreads to the central nervous system via neural and hematogenous routes and infects neurons, causing lethal encephalitis. These serotype-dependent differences in tropisms and pathogenesis are thought to be involved in the distinct binding with glycochain moieties.
Rotavirus (RoV) is a member of the genus Rotavirus and the most important pathogen of severe gastroenteritis in children. There are two groups of RoV in the hemagglutination activity of erythrocytes and sialidase sensitivity of viral infection: sialic acid-dependent and sialic acid-independent RoVs (Isa et al. 2006). A few animal RoVs are sialic acid dependent on the interactions of the viral surface spike VP8* protein, which is formed from the viral VP4 protein by proteolytic cleavage, with sialic acids, whereas human RoVs and the majority of animal RoVs are sialic acid independent. For cell entry, sialic acid-dependent RoVs require gangliosides containing Neu5Ac and/or Neu5Gc, such as GM1(a), GM2, GM3, GD1a, GD1b, GD3, and GT1b, which can inhibit RoV infection (Guo et al. 1999; Martínez et al. 2013; Rolsma et al. 1998; Superti and Donelli 1991; Yu et al. 2012). In addition, some sialic acid-independent RoVs, such as Wa and KUN strains, bind to GM1(a) containing internal Neu5Ac, which can also inhibit infections of these viruses (Guo et al. 1999; Haselhorst et al. 2009; Martínez et al. 2013). These studies suggest that sialic acid-dependent RoVs bind to gangliosides containing terminal Neu5Ac, whereas sialic acid-independent RoVs bind to gangliosides containing internal Neu5Ac. The VP8* protein of human sialic acid-independent RoVs also recognizes histo-blood group antigens, trisaccharide GalNAcα1,3(Fucα1,2)Gal of A antigen for HAL1166 P[11] viral genotype strain (Hu et al. 2012), H1 antigen for P[4] and P[8] viral genotypes, and Leb antigen for the P[6] viral genotype (Huang et al. 2012). The interactions of RoVs with sialo- or asialo-receptors are dependent on viral strains and genotypes. Nonstructural glycoprotein 4 (NSP4) encoded by RoVs is believed to function as an enterotoxin. NSP4 is secreted as an oligomeric lipoprotein from infected cells and binds to sulfated GAGs (Didsbury et al. 2011). Thus, glycans appear to be involved in the infection and pathogenesis of RoVs and NSP4 through cellular surface attachment (Table 5.10).
5.3 Conclusion
A variety of viruses recognize glycans such as sialoglycoconjugates, GAGs, and histo-blood group antigens. These glycans are often thought to serve as receptors and/or coreceptors for cellular surface attachment and cell entry of viruses and viral toxins. The interactions of viruses with glycans determine virus-dependent tissue tropism, host, and pathogenicity. In rare cases, the interaction of IAV HA with sulfatide functions as a start switch of progeny virus particle formation, not as a receptor for IAV infection. It may be important to evaluate the interactions of viruses with glycans in terms of insights different from a receptor function. Further studies combining virology and glycobiology should lead to the elucidation and discovery of novel infection and replication mechanisms of a variety of viruses.
Abbreviations
- AAV:
-
Adeno-associated virus
- AAV1:
-
AAV type 1
- AAV2:
-
AAV type 2
- AAV4:
-
AAV type 4
- AAV5:
-
AAV type 5
- AAV6:
-
AAV type 6
- AAV9:
-
AAV type 9
- AIBV:
-
Avian infectious bronchitis virus
- ApoE:
-
Apolipoprotein E
- BCV:
-
Bovine coronavirus
- BKV:
-
BK virus
- BPV:
-
Bovine parvovirus
- CPV:
-
Canine parvovirus
- DEN:
-
Dengue virus
- GAG:
-
Glycosaminoglycan
- GalCer:
-
Galactosylceramide
- HA:
-
Hemagglutinin
- HCoV-OC43:
-
Human coronavirus OC43 strain
- HCV:
-
Hepatitis C virus
- HE:
-
Hemagglutinin-esterase
- HN:
-
Hemagglutinin-neuraminidase
- HIV:
-
Human immunodeficiency virus
- HPAI:
-
Highly pathogenic avian IAV
- FPV:
-
Feline parvovirus
- hPIV:
-
Human parainfluenza virus
- hPIV1:
-
hPIV type 1
- hPIV3:
-
hPIV type 3
- HSV:
-
Herpes simplex virus
- HSV-1:
-
HSV serotype 1
- HSV-2:
-
HSV serotype 2
- IAV:
-
Influenza A virus
- IBV:
-
Influenza B virus
- ICV:
-
Influenza C virus
- JCV:
-
JC virus
- JEV:
-
Japanese encephalitis virus
- MHV:
-
Mouse hepatitis virus
- MVM:
-
Parvovirus minute virus of mice
- MPV:
-
Murine polyomavirus
- Neu5Ac:
-
N-Acetylneuraminic acid
- MuV:
-
Mumps virus
- NDV:
-
Newcastle disease virus
- Neu5Acα2,3Gal:
-
Neu5Ac α2,3-linked to galactose
- Neu4,5Ac2 :
-
N-Acetyl-4-O-acetylneuraminic acid
- Neu5,9Ac2 :
-
N-Acetyl-9-O-acetylneuraminic acid
- Neu5,9Ac2α2,3Gal:
-
Neu5,9Ac2 α2,3-linked to galactose
- Neu5,9Ac2α2,6Gal:
-
Neu5,9Ac2 α2,6-linked to galactose
- Neu5Gc:
-
N-Glycolylneuraminic acid
- NoV:
-
Human norovirus
- NSP4:
-
Nonstructural glycoprotein 4
- ReV:
-
Reovirus
- ReV1:
-
ReV type 1
- ReV3:
-
ReV type 3
- RoV:
-
Rotavirus
- RSV:
-
Human respiratory syncytial virus
- SeV:
-
Sendai virus
- SV40:
-
Simian virus 40
- TGEV:
-
Porcine transmissible gastroenteritis virus
- TNF:
-
Tumor necrosis factor
- VLP:
-
Virus-like particle
- vRNP:
-
Viral ribonucleoprotein complexes
- WNV:
-
West Nile virus
References
Abd El Rahman S, El-Kenawy AA, Neumann U et al (2009) Comparative analysis of the sialic acid binding activity and the tropism for the respiratory epithelium of four different strains of avian infectious bronchitis virus. Avian Pathol 38(1):41–45
Ali MM, Karasneh GA, Jarding MJ et al (2012) A 3-O-sulfated heparan sulfate binding peptide preferentially targets herpes simplex virus 2-infected cells. J Virol 86(12):6434–6443
Aoki C, Hidari KI, Itonori S et al (2006) Identification and characterization of carbohydrate molecules in mammalian cells recognized by dengue virus type 2. J Biochem 139(3):607–614
Banfield BW, Leduc Y, Esford L et al (1995) Sequential isolation of proteoglycan synthesis mutants by using herpes simplex virus as a selective agent: evidence for a proteoglycan-independent virus entry pathway. J Virol 69(6):3290–3298
Barth H, Schafer C, Adah MI et al (2003) Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. J Biol Chem 278(42):41003–41012
Barton ES, Connolly JL, Forrest JC et al (2001) Utilization of sialic acid as a coreceptor enhances reovirus attachment by multistep adhesion strengthening. J Biol Chem 276(3):2200–2211
Baum LG, Paulson JC (1990) Sialyloligosaccharides of the respiratory epithelium in the selection of human influenza virus receptor specificity. Acta Histochem Suppl 40:35–38
Bender FC, Whitbeck JC, Lou H et al (2005) Herpes simplex virus glycoprotein B binds to cell surfaces independently of heparan sulfate and blocks virus entry. J Virol 79(18):11588–11597
Bingham RW, Madge MH, Tyrrell DA (1975) Haemagglutination by avian infectious bronchitis virus-a coronavirus. J Gen Virol 28(3):381–390
Blackburn SD, Cline SE, Hemming JP et al (2005) Attachment of bovine parvovirus to O-linked alpha 2,3 neuraminic acid on glycophorin A. Arch Virol 150(7):1477–1484
Bose S, Banerjee AK (2002) Role of heparan sulfate in human parainfluenza virus type 3 infection. Virology 298(1):73–83
Bourgeois C, Bour JB, Lidholt K et al (1998) Heparin-like structures on respiratory syncytial virus are involved in its infectivity in vitro. J Virol 72(9):7221–7227
Chen Y, Maguire T, Hileman RE et al (1997) Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med 3(8):866–871
Chen Y, Tan M, Xia M et al (2011) Crystallography of a Lewis-binding norovirus, elucidation of strain-specificity to the polymorphic human histo-blood group antigens. PLoS Pathog 7(7):e1002152
Childs RA, Palma AS, Wharton S et al (2009) Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray. Nat Biotechnol 27(9):797–799
Chu VC, Whittaker GR (2004) Influenza virus entry and infection require host cell N-linked glycoprotein. Proc Natl Acad Sci U S A 101(52):18153–18158
Copeland R, Balasubramaniam A, Tiwari V et al (2008) Using a 3-O-sulfated heparin octasaccharide to inhibit the entry of herpes simplex virus type 1. Biochemistry 47(21):5774–5783
Crublet E, Andrieu JP, Vivés RR et al (2008) The HIV-1 envelope glycoprotein gp120 features four heparan sulfate binding domains, including the co-receptor binding site. J Biol Chem 283(22):15193–15200
Dalrymple N, Mackow ER et al (2011) Productive dengue virus infection of human endothelial cells is directed by heparan sulfate-containing proteoglycan receptors. J Virol 85(18):9478–9485
Delézay O, Hammache D, Fantini J et al (1996) SPC3, a V3 loop-derived synthetic peptide inhibitor of HIV-1 infection, binds to cell surface glycosphingolipids. Biochemistry 35(49):15663–15671
Delézay O, Koch N, Yahi N et al (1997) Co-expression of CXCR4/fusin and galactosylceramide in the human intestinal epithelial cell line HT-29. AIDS 11(11):1311–1318
Didsbury A, Wang C, Verdon D et al (2011) Rotavirus NSP4 is secreted from infected cells as an oligomeric lipoprotein and binds to glycosaminoglycans on the surface of non-infected cells. Virol J 8:551
Dugan AS, Eash S, Atwood WJ (2005) An N-linked glycoprotein with α(2,3)-linked sialic acid is a receptor for BK virus. J Virol 79(22):14442–14445
Dugan AS, Gasparovic ML, Tsomaia N et al (2007) Identification of amino acid residues in BK virus VP1 that are critical for viability and growth. J Virol 81(21):11798–11808
Dugan AS, Gasparovic ML, Atwood WJ (2008) Direct correlation between sialic acid binding and infection of cells by two human polyomaviruses (JC virus and BK virus). J Virol 82(5):2560–2564
Feldman SA, Hendry RM, Beeler JA (1999) Identification of a linear heparin binding domain for human respiratory syncytial virus attachment glycoprotein G. J Virol 73(8):6610–6617
Feldman SA, Audet S, Beeler JA (2000) The fusion glycoprotein of human respiratory syncytial virus facilitates virus attachment and infectivity via an interaction with cellular heparan sulfate. J Virol 74(14):6442–6447
Ferreira L, Villar E, Muñoz-Barroso I (2004) Gangliosides and N-glycoproteins function as Newcastle disease virus receptors. Int J Biochem Cell Biol 36(11):2344–2356
Gambaryan AS, Tuzikov AB, Pazynina GV et al (2008) 6-sulfo sialyl Lewis X is the common receptor determinant recognized by H5, H6, H7 and H9 influenza viruses of terrestrial poultry. Virol J 5:85
Gambaryan AS, Matrosovich TY, Philipp J et al (2012) Receptor-binding profiles of H7 subtype influenza viruses in different host species. J Virol 86(8):4370–4379
Gee GV, Tsomaia N, Mierke DF et al (2004) Modeling a sialic acid binding pocket in the external loops of JC virus VP1. J Biol Chem 279(47):49172–49176
Gentsch JR, Pacitti AF (1987) Differential interaction of reovirus type 3 with sialylated receptor components on animal cells. Virology 161(1):245–248
Guo CT, Nakagomi O, Mochizuki M et al (1999) Ganglioside GM(1a) on the cell surface is involved in the infection by human rotavirus KUN and MO strains. J Biochem 126(4):683–688
Hallak LK, Collins PL, Knudson W et al (2000) Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection. Virology 271(2):264–275
Hammache D, Piéroni G, Yahi N et al (1998) Specific interaction of HIV-1 and HIV-2 surface envelope glycoproteins with monolayers of galactosylceramide and ganglioside GM3. J Biol Chem 273(14):7967–7971
Hansson GC, Karlsson KA, Larson G et al (1984) A novel approach to the study of glycolipid receptors for viruses. Binding of Sendai virus to thin-layer chromatograms. FEBS Lett 170(1):15–18
Harouse JM, Bhat S, Spitalnik SL et al (1991) Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science 253(5017):320–323
Harrington PR, Lindesmith L, Yount B et al (2002) Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice. J Virol 76(23):12335–12343
Haselhorst T, Fleming FE, Dyason JC et al (2009) Sialic acid dependence in rotavirus host cell invasion. Nat Chem Biol 5(2):91–93
Helander A, Silvey KJ, Mantis NJ et al (2003) The viral σ protein and glycoconjugates containing α2-3-linked sialic acid are involved in type 1 reovirus adherence to M cell apical surfaces. J Virol 77(14):7964–7977
Heo TH (2008) A potential role of the heparan sulfate in the hepatitis C virus attachment. Acta Virol 52(1):7–15
Herfst S, Schrauwen EJ, Linster M et al (2012) Airborne transmission of influenza A/H5N1 virus between ferrets. Science 336(6088):1534–1541
Herold BC, WuDunn D, Soltys N et al (1991) Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J Virol 65(3):1090–1098
Hidari KI, Takahashi N, Arihara M et al (2008) Structure and anti-dengue virus activity of sulfated polysaccharide from a marine alga. Biochem Biophys Res Commun 376(1):91–95
Hidari KI, Ikeda K, Watanabe I et al (2012) 3-O-sulfated glucuronide derivative as a potential anti-dengue virus agent. Biochem Biophys Res Commun 424(3):573–578
Hu L, Crawford SE, Czako R et al (2012) Cell attachment protein VP8* of a human rotavirus specifically interacts with A-type histo-blood group antigen. Nature 485(7397):256–259
Huang P, Farkas T, Marionneau S et al (2003) Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns. J Infect Dis 188(1):19–31
Huang P, Farkas T, Zhong W et al (2005) Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J Virol 79(11):6714–6722
Huang P, Xia M, Tan M et al (2012) Spike protein VP8* of human rotavirus recognizes histo-blood group antigens in a type-specific manner. J Virol 86(9):4833–4843
Hutson AM, Atmar RL, Graham DY et al (2002) Norwalk virus infection and disease is associated with ABO histo-blood group type. J Infect Dis 185(9):1335–1337
Hutson AM, Atmar RL, Marcus DM et al (2003) Norwalk virus-like particle hemagglutination by binding to h histo-blood group antigens. J Virol 77(1):405–415
Imai M, Watanabe T, Hatta M et al (2012) Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 486(7403):420–428
Isa P, Arias CF, López S (2006) Role of sialic acids in rotavirus infection. Glycoconj J 23(1–2):27–37
Ito T, Suzuki Y, Mitnaul L et al (1997a) Receptor specificity of influenza A viruses correlates with the agglutination of erythrocytes from different animal species. Virology 227(2):493–499
Ito T, Suzuki Y, Takada A et al (1997b) Differences in sialic acid-galactose linkages in the chicken egg amnion and allantois influence human influenza virus receptor specificity and variant selection. J Virol 71(4):3357–3362
Ito T, Suzuki Y, Suzuki T et al (2000) Recognition of N-glycolylneuraminic acid linked to galactose by the α2,3 linkage is associated with intestinal replication of influenza A virus in ducks. J Virol 74(19):9300–9305
Jiang J, Cun W, Wu X et al (2012) Hepatitis C virus attachment mediated by apolipoprotein E binding to cell surface heparan sulfate. J Virol 86(13):7256–7267
Johnson FB, Fenn LB, Owens TJ et al (2004) Attachment of bovine parvovirus to sialic acids on bovine cell membranes. J Gen Virol 85(Pt 8):2199–2207
Kaludov N, Brown KE, Walters RW et al (2001) Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity. J Virol 75(15):6884–6893
Kato D, Era S, Watanabe I et al (2010) Antiviral activity of chondroitin sulphate E targeting dengue virus envelope protein. Antiviral Res 88(2):236–243
Kobayashi F, Yamada S, Taguwa S et al (2012) Specific interaction of the envelope glycoproteins E1 and E2 with liver heparan sulfate involved in the tissue tropismatic infection by hepatitis C virus. Glycoconj J 29(4):211–220
Komagome R, Sawa H, Suzuki T et al (2002) Oligosaccharides as receptors for JC virus. J Virol 76(24):12992–13000
Krempl C, Schultze B, Herrler G (1995) Analysis of cellular receptors for human coronavirus OC43. Adv Exp Med Biol 380:371–374
Künkel F, Herrler G (1993) Structural and functional analysis of the surface protein of human coronavirus OC43. Virology 195(1):195–202
Langereis MA, Zeng Q, Heesters BA et al (2012) The murine coronavirus hemagglutinin-esterase receptor-binding site: a major shift in ligand specificity through modest changes in architecture. PLoS Pathog 8(1):e1002492
Laquerre S, Argnani R, Anderson DB et al (1998) Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread. J Virol 72(7):6119–6130
Lee E, Hall RA, Lobigs M (2004) Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses. J Virol 78(15):8271–8280
Lindesmith L, Moe C, Marionneau S et al (2003) Human susceptibility and resistance to Norwalk virus infection. Nat Med 9(5):548–553
Liu CK, Wei G, Atwood WJ (1998) Infection of glial cells by the human polyomavirus JC is mediated by an N-linked glycoprotein containing terminal α(2–6)-linked sialic acids. J Virol 72(6):4643–4649
Löfling J, Michael Lyi S, Parrish CR et al (2013) Canine and feline parvoviruses preferentially recognize the non-human cell surface sialic acid N-glycolylneuraminic acid. Virology 440(1):89–96
Lund N, Branch DR, Mylvaganam M et al (2006) A novel soluble mimic of the glycolipid, globotriaosyl ceramide inhibits HIV infection. AIDS 20(3):333–343
Madu IG, Chu VC, Lee H et al (2007) Heparan sulfate is a selective attachment factor for the avian coronavirus infectious bronchitis virus Beaudette. Avian Dis 51(1):45–51
Mahfoud R, Mylvaganam M, Lingwood CA et al (2002) A novel soluble analog of the HIV-1 fusion cofactor, globotriaosylceramide (Gb3), eliminates the cholesterol requirement for high affinity gp120/Gb3 interaction. J Lipid Res 43(10):1670–1679
Marionneau S, Ruvoën N, Le Moullac-Vaidye B et al (2002) Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals. Gastroenterology 122(7):1967–1977
Marks RM, Lu H, Sundaresan R et al (2001) Probing the interaction of dengue virus envelope protein with heparin: assessment of glycosaminoglycan-derived inhibitors. J Med Chem 44(13):2178–2187
Markwell MA, Svennerholm L, Paulson JC (1981) Specific gangliosides function as host cell receptors for Sendai virus. Proc Natl Acad Sci U S A 78(9):5406–5410
Martínez MA, López S, Arias CF et al (2013) Gangliosides have a functional role during rotavirus cell entry. J Virol 87(2):1115–1122
Masuda H, Suzuki T, Sugiyama Y et al (1999) Substitution of amino acid residue in influenza A virus hemagglutinin affects recognition of sialyl-oligosaccharides containing N-glycolylneuraminic acid. FEBS Lett 464(1–2):71–74
Nam HJ, Gurda-Whitaker B, Gan WY et al (2006) Identification of the sialic acid structures recognized by minute virus of mice and the role of binding affinity in virulence adaptation. J Biol Chem 281(35):25670–25677
Neu U, Maginnis MS, Palma AS et al (2010) Structure-function analysis of the human JC polyomavirus establishes the LSTc pentasaccharide as a functional receptor motif. Cell Host Microbe 8(4):309–319
O’Donnell CD, Kovacs M, Akhtar J et al (2010) Expanding the role of 3-O sulfated heparan sulfate in herpes simplex virus type-1 entry. Virology 397(2):389–398
Pokorný J, Brůcková M, Rýc M (1975) Biophysical properties of coronavirus strain OC 43. Acta Virol 19(2):137–142
Regl G, Kaser A, Iwersen M et al (1999) The hemagglutinin-esterase of mouse hepatitis virus strain S is a sialate-4-O-acetylesterase. J Virol 73(6):4721–4727
Reiss K, Stencel JE, Liu Y et al (2012) The GM2 glycan serves as a functional coreceptor for serotype 1 reovirus. PLoS Pathog 8(12):e1003078
Reiter DM, Frierson JM, Halvorson EE et al (2011) Crystal structure of reovirus attachment protein σ1 in complex with sialylated oligosaccharides. PLoS Pathog 7(8):e1002166
Rockx BH, Vennema H, Hoebe CJ et al (2005) Association of histo-blood group antigens and susceptibility to norovirus infections. J Infect Dis 191(5):749–754
Rogers GN, Herrler G, Paulson JC et al (1986) Influenza C virus uses 9-O-acetyl-N-acetylneuraminic acid as a high affinity receptor determinant for attachment to cells. J Biol Chem 261(13):5947–5951
Rolsma MD, Kuhlenschmidt TB, Gelberg HB et al (1998) Structure and function of a ganglioside receptor for porcine rotavirus. J Virol 72(11):9079–9091
Sánchez-Felipe L, Villar E, Muñoz-Barroso I (2012) α2-3- and α2-6- N-linked sialic acids allow efficient interaction of Newcastle Disease Virus with target cells. Glycoconj J 29(7):539–549
Schultze B, Herrler G (1992) Bovine coronavirus uses N-acetyl-9-O-acetylneuraminic acid as a receptor determinant to initiate the infection of cultured cells. J Gen Virol 73(4):901–906
Schultze B, Gross HJ, Brossmer R et al (1991a) The S protein of bovine coronavirus is a hemagglutinin recognizing 9-O-acetylated sialic acid as a receptor determinant. J Virol 65(11):6232–6237
Schultze B, Wahn K, Klenk HD et al (1991b) Isolated HE-protein from hemagglutinating encephalomyelitis virus and bovine coronavirus has receptor-destroying and receptor-binding activity. Virology 180(1):221–228
Schultze B, Cavanagh D, Herrler G (1992) Neuraminidase treatment of avian infectious bronchitis coronavirus reveals a hemagglutinating activity that is dependent on sialic acid-containing receptors on erythrocytes. Virology 189(2):792–794
Schultze B, Enjuanes L, Cavanagh D et al (1993) N-acetylneuraminic acid plays a critical role for the haemagglutinating activity of avian infectious bronchitis virus and porcine transmissible gastroenteritis virus. Adv Exp Med Biol 342:305–310
Schultze B, Krempl C, Ballesteros ML et al (1996) Transmissible gastroenteritis coronavirus, but not the related porcine respiratory coronavirus, has a sialic acid (N-glycolylneuraminic acid) binding activity. J Virol 70(8):5634–5637
Schwegmann-Wessels C, Herrler G (2008) Identification of sugar residues involved in the binding of TGEV to porcine brush border membranes. Methods Mol Biol 454:319–329
Shahwan K, Hesse M, Mork AK et al (2013) Sialic acid binding properties of soluble coronavirus spike (S1) proteins: differences between infectious bronchitis virus and transmissible gastroenteritis virus. Viruses 5(8):1924–1933
Shen S, Bryant KD, Brown SM et al (2011) Terminal N-linked galactose is the primary receptor for adeno-associated virus 9. J Biol Chem 286(15):13532–13540
Shi Q, Jiang J, Luo G (2013) Syndecan-1 serves as the major receptor for attachment of hepatitis C virus to the surfaces of hepatocytes. J Virol 87(12):6866–6875
Shirato H, Ogawa S, Ito H et al (2008) Noroviruses distinguish between type 1 and type 2 histo-blood group antigens for binding. J Virol 82(21):10756–10767
Shirato-Horikoshi H, Ogawa S, Wakita T et al (2007) Binding activity of norovirus and sapovirus to histo-blood group antigens. Arch Virol 152(3):457–461
Shukla D, Liu J, Blaiklock P et al (1999) A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 99(1):13–22
Sinaniotis CA (2004) Viral pneumoniae in children: incidence and aetiology. Paediatr Respir Rev 5(Suppl A):S197–S200
Spear PG, Eisenberg RJ, Cohen GH (2000) Three classes of cell surface receptors for alphaherpesvirus entry. Virology 275(1):1–8
Su CM, Liao CL, Lee YL et al (2001) Highly sulfated forms of heparin sulfate are involved in Japanese encephalitis virus infection. Virology 286(1):206–215
Summerford C, Samulski RJ (1998) Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol 72(2):1438–1445
Superti F, Donelli G (1991) Gangliosides as binding sites in SA-11 rotavirus infection of LLC-MK2 cells. J Gen Virol 72(10):2467–2474
Suzuki Y (1994) Gangliosides as influenza virus receptors. Variation of influenza viruses and their recognition of the receptor sialo-sugar chains. Prog Lipid Res 33(4):429–457
Suzuki Y, Suzuki T, Matsumoto M (1983) Isolation and characterization of receptor sialoglycoprotein for hemagglutinating virus of Japan (Sendai virus) from bovine erythrocyte membrane. J Biochem 93(6):1621–1633
Suzuki T, Harada M, Suzuki Y et al (1984) Incorporation of sialoglycoprotein containing lacto-series oligosaccharides into chicken asialoerythrocyte membranes and restoration of receptor activity toward hemagglutinating virus of Japan (Sendai virus). J Biochem 95(4):1193–1200
Suzuki Y, Suzuki T, Matsunaga M et al (1985) Gangliosides as paramyxovirus receptor. Structural requirement of sialo-oligosaccharides in receptors for hemagglutinating virus of Japan (Sendai virus) and Newcastle disease virus. J Biochem 97(4):1189–1199
Suzuki Y, Nakao T, Ito T et al (1992) Structural determination of gangliosides that bind to influenza A, B, and C viruses by an improved binding assay: strain-specific receptor epitopes in sialo-sugar chains. Virology 189(1):121–131
Suzuki T, Sometani A, Yamazaki Y et al (1996) Sulphatide binds to human and animal influenza A viruses, and inhibits the viral infection. Biochem J 318(Pt 2):389–393
Suzuki T, Horiike G, Yamazaki Y et al (1997) Swine influenza virus strains recognize sialylsugar chains containing the molecular species of sialic acid predominantly present in the swine tracheal epithelium. FEBS Lett 404(2–3):192–196
Suzuki Y, Ito T, Suzuki T et al (2000) Sialic acid species as a determinant of the host range of influenza A viruses. J Virol 74(24):11825–11831
Suzuki T, Portner A, Scroggs RA et al (2001) Receptor specificities of human respiroviruses. J Virol 75(10):4604–4613
Takahashi T, Suzuki T (2012) Role of sulfatide in normal and pathological cells and tissues. J Lipid Res 53(8):1437–1450
Takahashi T, Murakami K, Nagakura M et al (2008) Sulfatide is required for efficient replication of influenza A virus. J Virol 82(12):5940–5950
Takahashi T, Hashimoto A, Maruyama M et al (2009) Identification of amino acid residues of influenza A virus H3 HA contributing to the recognition of molecular species of sialic acid. FEBS Lett 583(19):3171–3174
Takahashi T, Satoh H, Takaguchi M et al (2010) Binding of sulphatide to recombinant haemagglutinin of influenza A virus produced by a baculovirus protein expression system. J Biochem 147(4):459–462
Takahashi T, Ito K, Fukushima K et al (2012) Sulfatide negatively regulates the fusion process of human parainfluenza virus type 3. J Biochem 152(4):373–380
Takahashi T, Kawagishi S, Masuda M et al (2013a) Binding kinetics of sulfatide with influenza A virus hemagglutinin. Glycoconj J 30(7):709–716
Takahashi T, Takaguchi M, Kawakami T et al (2013b) Sulfatide regulates caspase-3-independent apoptosis of influenza A virus through viral PB1-F2 protein. PLoS One 8(4):e61092
Tappert MM, Smith DF, Air GM (2011) Fixation of oligosaccharides to a surface may increase the susceptibility to human parainfluenza virus 1, 2, or 3 hemagglutinin-neuraminidase. J Virol 85(23):12146–12159
Tresnan DB, Southard L, Weichert W et al (1995) Analysis of the cell and erythrocyte binding activities of the dimple and canyon regions of the canine parvovirus capsid. Virology 211(1):123–132
Trybala E, Liljeqvist JA, Svennerholm B et al (2000) Herpes simplex virus types 1 and 2 differ in their interaction with heparan sulfate. J Virol 74(19):9106–9114
Tsai B, Gilbert JM, Stehle T et al (2003) Gangliosides are receptors for murine polyoma virus and SV40. EMBO J 22(17):4346–4355
van den Berg LH, Sadiq SA, Lederman S et al (1992) The gp120 glycoprotein of HIV-1 binds to sulfatide and to the myelin associated glycoprotein. J Neurosci Res 33(4):513–518
Walters RW, Yi SM, Keshavjee S et al (2001) Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer. J Biol Chem 276(23):20610–20616
Watanabe T, Kiso M, Fukuyama S et al (2013) Characterization of H7N9 influenza A viruses isolated from humans. Nature. doi:10.1038/nature12392
Watterson D, Kobe B, Young PR (2012) Residues in domain III of the dengue virus envelope glycoprotein involved in cell-surface glycosaminoglycan binding. J Gen Virol 93(1):72–82
Waxham MN, Wolinsky JS (1986) A fusing mumps virus variant selected from a nonfusing parent with the neuraminidase inhibitor 2-deoxy-2,3-dehydro-N-acetylneuraminic acid. Virology 151(2):286–295
Wichit S, Jittmittraphap A, Hidari KI et al (2011) Dengue virus type 2 recognizes the carbohydrate moiety of neutral glycosphingolipids in mammalian and mosquito cells. Microbiol Immunol 55(2):135–140
Winter C, Schwegmann-Wessels C, Cavanagh D et al (2006) Sialic acid is a receptor determinant for infection of cells by avian Infectious bronchitis virus. J Gen Virol 87(5):1209–1216
Wu Z, Miller E, Agbandje-McKenna M et al (2006) α2,3 and α2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6. J Virol 80(18):9093–9103
Wurzer WJ, Planz O, Ehrhardt C et al (2003) Caspase 3 activation is essential for efficient influenza virus propagation. EMBO J 22(11):2717–2728
Wybenga LE, Epand RF, Nir S et al (1996) Glycophorin as a receptor for Sendai virus. Biochemistry 35(29):9513–9518
Yamada S, Suzuki Y, Suzuki T et al (2006) Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature 444(7117):378–382
Yu X, Dang VT, Fleming FE et al (2012) Structural basis of rotavirus strain preference toward N-acetyl- or N-glycolylneuraminic acid-containing receptors. J Virol 86(24):13456–13466
Zhang Q, Shi J, Deng G et al (2013) H7N9 influenza viruses are transmissible in ferrets by respiratory droplet. Science 341(6144):410–414
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Japan
About this chapter
Cite this chapter
Takahashi, T., Suzuki, T. (2015). Role of Glycans in Viral Infection. In: Suzuki, T., Ohtsubo, K., Taniguchi, N. (eds) Sugar Chains. Springer, Tokyo. https://doi.org/10.1007/978-4-431-55381-6_5
Download citation
DOI: https://doi.org/10.1007/978-4-431-55381-6_5
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-55380-9
Online ISBN: 978-4-431-55381-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)